Professor Sunil Lakhani

MBP Home About Team Research Training Donate MBP Contact
Group Leader
  Brisbane Breast Bank

Professor Sunil Lakhani
B.Sc (Hons), MBBS, MD, FRC.Path, FRCPA

Head of Molecular Breast Pathology, UQCCR
Director of Anatomical Pathology, Pathology Queensland
Head of the discipline of Cell and Molecular Pathology, UQ School of Medicine
NHMRC Program Leader

Sunil is a diagnostic and molecular pathologist with an international reputation in the classification of breast disease, and molecular analysis of pre-invasive and invasive breast lesions. Before moving to Australia in 2004, he was Professor of Breast Pathology at The Institute of Cancer Research and Royal Marsden Hospital in London.

He holds appointments at The University of Queensland (Head of the Molecular Breast Pathology Group at the UQCCR, Head of the discipline of Molecular and Cellular Pathology in the UQ School of Medicine), Pathology Queensland (State Director of Anatomical Pathology) and is an active member of the Royal Brisbane and Women’s Hospital (RBWH) Clinical Breast Unit, the ANZ Breast Cancer Trials group (ANZBCTG) and the International Cancer Genome Consortium (ICGC) Breast Pathology Group. He is Series Editor of the World Health Organisation (WHO) ‘blue books’ and Editor of the WHO Classification Tumours of the Breast 4th-Ed (2012). 

Sunil’s published works exceed 350 original research articles, reviews and book chapters, which have collectively been cited more than 19,000 times by others. His work on pre-invasive lesions has informed clinical management in the BreastScreen program, and research on familial breast cancer has impacted on the management of patients with inherited predisposition.

His current research interests include lobular breast cancer and its variants, normal breast and stem cells, basal-like tumours, mechanisms underpinning brain and other distant metastases and familial breast cancer. He also heads the UQ Medicine and Biomedical Sciences Faculty Breast Cancer Research Initiative which aims to integrate breast cancer research efforts throughout the Brisbane area, spanning the full spectrum of basic, translational and clinical research.